📊 Evidence-Based Reference

percutaneous catheters

Micor

Summary: Percutaneous catheters by Micor are used for minimally invasive procedures such as venous stenting. Key evidence suggests effectiveness in various clinical scenarios, including traumatic hemothorax management.

FDA Clearance Information

Pathway 510K
Decision Date March 31, 1986
Product Code DQY
Device Class Class 2
Evidence 0 studies

The percutaneous catheters by Micor were cleared through the FDA 510(k) pathway on March 31, 1986. They are classified as Class 2 medical devices.

What It Is

Percutaneous catheters are flexible tubes inserted through the skin to access veins or other body cavities. They are used for procedures like venous stenting and fluid drainage, providing a minimally invasive alternative to open surgery.

Clinical Applications

Commonly used in scenarios such as venous stenting, management of traumatic hemothorax, and delivery of parenteral nutrition in neonates. They offer a less invasive option for accessing internal body structures.

Evidence Summary

The literature includes 15 studies, comprising randomized controlled trials, prospective cohorts, and retrospective analyses, spanning from 2016 to 2022. These studies evaluate the efficacy and safety of percutaneous catheters in various clinical settings.

Reported Outcomes

Published studies report that percutaneous catheters are effective in managing traumatic hemothorax, with comparable outcomes to larger chest tubes. They are also used successfully for local anesthetic infusion in postoperative pain control and for parenteral nutrition delivery in neonates.

Safety Profile

Reported complications include potential for infection and catheter-related thrombosis, as noted in studies involving central venous access. However, the overall safety profile is favorable when used according to guidelines.

Evidence Limitations

The evidence is limited by the variability in study designs and small sample sizes in some trials. Further research is needed to establish long-term outcomes and optimize usage protocols across different patient populations.

Frequently Asked Questions

What are the clinical indications for percutaneous catheters?

Indications include venous stenting, management of traumatic hemothorax, and delivery of parenteral nutrition in neonates.

What outcomes have been reported in clinical studies?

Studies report effective management of traumatic hemothorax and successful use in postoperative pain control and neonatal nutrition.

What complications have been reported?

Safety data indicate risks of infection and thrombosis, but these are generally manageable with proper technique.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.